Systematic literature review of the humanistic and economic burden of focal epilepsy and primary generalized tonic-clonic seizures in adults
- PMID: 39291709
- PMCID: PMC11633719
- DOI: 10.1002/epi4.13011
Systematic literature review of the humanistic and economic burden of focal epilepsy and primary generalized tonic-clonic seizures in adults
Abstract
This systematic literature review (SLR) assessed the humanistic and economic burden of focal epilepsy and primary generalized tonic-clonic seizures (PGTCS) in adults to evaluate these domains in both populations and identify evidence gaps to inform future research. A search was conducted on December 7, 2022, using MEDLINE and Embase to identify studies published from 2012 onwards reporting humanistic burden (patient-reported or caregiver-reported outcomes or utilities, qualitative evaluations), economic burden (productivity loss, caregiver and societal costs of epilepsy), and sleep-related outcomes. Of the 2830 citations identified, 136 were included. Most studies were in the focal epilepsy population; very few studies reported outcomes in the PGTCS population. The presence of epilepsy-specific instruments varied based on the domain evaluated. Epilepsy exerted considerable humanistic and economic burden. Indicators of poor disease control (e.g., high seizure frequency, resistance to anti-seizure medications, polypharmacy) increased epilepsy burden. Seizure frequency and type, disease severity, and polypharmacy also affected work productivity. Adults with epilepsy, particularly focal epilepsy, reported higher indirect costs, more sick days accrued, and early entry into retirement. Caregivers similarly reported high productivity loss and absenteeism related to caregiving duties. The results of this SLR highlight the high humanistic and economic burden of focal epilepsy and PGTCS, although limited data were available for the PGTCS population. The results include patient-reported outcome data specific to focal epilepsy and PGTCS, expanding the limited humanistic burden evidence identified in previous reviews, and show the effect of poor disease control on individuals' lives and as a driver of indirect costs. PLAIN LANGUAGE SUMMARY: Our systematic literature review identified studies that evaluated the impact of focal epilepsy and primary generalized tonic-clonic seizures on patients and their caregivers. We found that focal epilepsy negatively impacted patients' mental health and sleep and was associated with higher indirect costs and lower work productivity in people with more severe disease. The impact of primary generalized tonic-clonic seizures on patients was rarely reported, and future research is needed.
Keywords: epilepsy; health‐related quality of life; indirect cost.
© 2024 Angelini Pharma. Chilli Consultancy and OPEN Health. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Conflict of interest statement
At the time of study conduct, EL and NB were employees of OPEN Health, which received consulting fees from Angelini to conduct the review; SB and GDD were employees of Angelini. SB is currently an employee of UCB. AN is a Director at Chilli Consultancy, which received consulting fees from Angelini to participate in the review.
Figures

Similar articles
-
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD001031. doi: 10.1002/14651858.CD001031.pub4. Cochrane Database Syst Rev. 2018. PMID: 29952431 Free PMC article.
-
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.Cochrane Database Syst Rev. 2016 Nov 14;11(11):CD001031. doi: 10.1002/14651858.CD001031.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2018 Jun 28;6:CD001031. doi: 10.1002/14651858.CD001031.pub4. PMID: 27841445 Free PMC article. Updated.
-
Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.Cochrane Database Syst Rev. 2016 Dec 6;12(12):CD012065. doi: 10.1002/14651858.CD012065.pub2. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2019 Jun 24;6:CD012065. doi: 10.1002/14651858.CD012065.pub3. PMID: 27922722 Free PMC article. Updated.
-
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.Cochrane Database Syst Rev. 2017 Jun 29;6(6):CD011412. doi: 10.1002/14651858.CD011412.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2017 Dec 15;12:CD011412. doi: 10.1002/14651858.CD011412.pub3. PMID: 28661008 Free PMC article. Updated.
-
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD001904. doi: 10.1002/14651858.CD001904.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2018 Oct 24;10:CD001904. doi: 10.1002/14651858.CD001904.pub4. PMID: 27976799 Free PMC article. Updated.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources